Halozyme Therapeutics, Inc. (HALO)
71.21
-0.61
(-0.85%)
USD |
NASDAQ |
Jan 16, 16:00
71.20
-0.01
(-0.01%)
After-Hours: 20:00
Halozyme Therapeutics EPS Diluted (TTM): 4.757 for Sept. 30, 2025
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Johnson & Johnson | 10.36 |
| Merck & Co., Inc. | 7.560 |
| AIM ImmunoTech, Inc. | -14.93 |
| Stryker Corp. | 7.616 |
| Skye Bioscience, Inc. | -1.290 |